Tejnaksh Healthcare539428Research publication
Peer-reviewed validation study of Pflow™ published in Indian Journal of Urology
Tejnaksh Healthcare said a peer-reviewed study validating its portable uroflowmetry device Pflow™ has been published in the Indian Journal of Urology.
By ScoutQuest · · 1 min read
- Patients in study
- 372 patients
- Study centres
- two tertiary urology centres
- Journal
- Indian Journal of Urology
What the company announced
- A research paper titled "Prospective Multicentric Validation of a Novel Uroflowmetry Device (Pflow™) Against Conventional Gravimetric Uroflowmetry" has been published in the Indian Journal of Urology, described as the official peer-reviewed journal of the Urological Society of India.
- The paper relates to Pflow™, a portable uroflowmetry device developed for urine flow assessment.
What the study involved
- A prospective multicentric study covering 372 patients across two tertiary urology centres.
- It compared the performance of Pflow™ with conventional gravimetric uroflowmetry.
- The publication reports that the device demonstrated agreement with conventional uroflowmetry parameters and supports its utility as a convenient and patient-friendly option for uroflowmetric evaluation.
Who is involved
- Dr. Ashish Rawandale-Patil, Managing Director of Tejnaksh Healthcare Limited, and Dr. Preeti Rawandale, Director of Tejnaksh Healthcare Limited, are listed among the contributing authors.
Earlier recognition mentioned
- The update notes that Pflow™ was featured on Shark Tank India Season 2 Episode 13, where the product was showcased to a national audience for its potential in uroflowmetry testing.
How the company frames it
- The company said the publication provides independent scientific validation of the technology and marks a milestone in translating indigenous medical innovation into evidence-based clinical practice.
- It added that the publication reinforces its focus on healthcare innovation, research and patient-centric medical solutions.
How to read this
- This is an update on scientific recognition of a product, with the study outcome described in qualitative terms such as "agreement with conventional uroflowmetry parameters".
- Such publications are typically relevant to how a device is viewed by clinicians and hospitals; the update presents the development as a validation milestone rather than a commercial or financial event.
Also from Tejnaksh Healthcare
Suhas Vasvantrao Thorat re-appointed Independent Director for a second term of 5 consecutive years
1 Oct 2026
More numbers
- Patients in the Pflow™ validation study372 patients
- Tertiary urology centres in the studytwo tertiary urology centers
Source: BSE · 24 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.